As hospitals around the country prepare for the possibility of treating a patient infected with Ebola, Canberra is pleased to offer many Cleaner / Disinfectants that meet the CDC recommended criteria for cleaning and disinfecting hard non-porous surfaces.
Ebola viruses are transmitted through direct contact with blood, body fluids, or substances of an infected person with symptoms or through exposure to objects that have been contaminated with infected blood or body fluids. Limited laboratory studies under favorable conditions indicate that the Ebola Virus can remain viable on solid surfaces, with concentrations falling slowly over several days. Therefore, it is important to use the appropriate products to disinfect solid surfaces.
Ebola is of the family of Filovirus which are susceptible to acetic acid, glutaraldehyde, bleach, alcohol (70% IPA), heat, sunlight (UVC), and gamma radiation. The CDC recommends the use of an EPA-registered hospital disinfectant with a label claim for non-enveloped virus (e.g., norovirus, rotavirus, adenovirus, poliovirus) to disinfect environmental surfaces in the rooms of patients with suspected or confirmed Ebola Virus infection. Although there are no products with specific label claims against the Ebola Virus, enveloped viruses such as Ebola are susceptible to a broad range of hospital disinfectants used to disinfect hard, non-porous surfaces. In contrast, non-enveloped viruses are more resistant to disinfectants. As a precaution, selection of a disinfectant product with a higher potency than what is normally required for an enveloped virus is being recommended at this time. EPA-registered hospital disinfectants with label claims against non-enveloped viruses (e.g., norovirus, rotavirus, adenovirus, poliovirus) are broadly antiviral and capable of inactivating both enveloped and non-enveloped viruses.
Canberra is pleased to offer the following products that meet these requirements.